These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30059794)

  • 21. D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia.
    Smits JA; Rosenfield D; Otto MW; Powers MB; Hofmann SG; Telch MJ; Pollack MH; Tart CD
    Biol Psychiatry; 2013 Jun; 73(11):1054-8. PubMed ID: 23332511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exposure-related cortisol predicts outcome of psychotherapy in veterans with treatment-resistant posttraumatic stress disorder.
    van Gelderen MJ; Nijdam MJ; de Vries F; Meijer OC; Vermetten E
    J Psychiatr Res; 2020 Nov; 130():387-393. PubMed ID: 32889356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder.
    Litz BT; Salters-Pedneault K; Steenkamp MM; Hermos JA; Bryant RA; Otto MW; Hofmann SG
    J Psychiatr Res; 2012 Sep; 46(9):1184-90. PubMed ID: 22694905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are 60-minute prolonged exposure sessions with 20-minute imaginal exposure to traumatic memories sufficient to successfully treat PTSD? A randomized noninferiority clinical trial.
    Nacasch N; Huppert JD; Su YJ; Kivity Y; Dinshtein Y; Yeh R; Foa EB
    Behav Ther; 2015 May; 46(3):328-41. PubMed ID: 25892169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Meta-Analysis of D-Cycloserine in Exposure-Based Treatment: Moderators of Treatment Efficacy, Response, and Diagnostic Remission.
    McGuire JF; Wu MS; Piacentini J; McCracken JT; Storch EA
    J Clin Psychiatry; 2017 Feb; 78(2):196-206. PubMed ID: 27314661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder.
    de Kleine RA; Hendriks GJ; Kusters WJ; Broekman TG; van Minnen A
    Biol Psychiatry; 2012 Jun; 71(11):962-8. PubMed ID: 22480663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does Traumatic Brain Injury Attenuate the Exposure Therapy Process?
    Ragsdale KA; Gramlich MA; Beidel DC; Neer SM; Kitsmiller EG; Morrison KI
    Behav Ther; 2018 Jul; 49(4):617-630. PubMed ID: 29937262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological enhancement of behavioral therapy: focus on posttraumatic stress disorder.
    Choi DC; Rothbaum BO; Gerardi M; Ressler KJ
    Curr Top Behav Neurosci; 2010; 2():279-99. PubMed ID: 21309114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virtual reality exposure therapy for Vietnam veterans with posttraumatic stress disorder.
    Rothbaum BO; Hodges LF; Ready D; Graap K; Alarcon RD
    J Clin Psychiatry; 2001 Aug; 62(8):617-22. PubMed ID: 11561934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. D-cycloserine augmented exposure therapy for obsessive-compulsive disorder.
    Kushner MG; Kim SW; Donahue C; Thuras P; Adson D; Kotlyar M; McCabe J; Peterson J; Foa EB
    Biol Psychiatry; 2007 Oct; 62(8):835-8. PubMed ID: 17588545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Habituation of distress and craving during treatment as predictors of change in PTSD symptoms and substance use severity.
    Badour CL; Flanagan JC; Gros DF; Killeen T; Pericot-Valverde I; Korte KJ; Allan NP; Back SE
    J Consult Clin Psychol; 2017 Mar; 85(3):274-281. PubMed ID: 28221062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating Relationships Between PTSD Symptom Clusters Within Virtual Reality Exposure Therapy for OEF/OIF Veterans.
    Maples-Keller JL; Price M; Rauch S; Gerardi M; Rothbaum BO
    Behav Ther; 2017 Mar; 48(2):147-155. PubMed ID: 28270326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pilot Study of a Telehealth-Delivered Medication-Augmented Exposure Therapy Protocol for PTSD.
    Olden M; Wyka K; Cukor J; Peskin M; Altemus M; Lee FS; Finkelstein-Fox L; Rabinowitz T; Difede J
    J Nerv Ment Dis; 2017 Feb; 205(2):154-160. PubMed ID: 27441461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.
    Hofmann SG; Carpenter JK; Otto MW; Rosenfield D; Smits JA; Pollack MH
    Contemp Clin Trials; 2015 Jul; 43():223-30. PubMed ID: 26111923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD).
    Reger GM; Koenen-Woods P; Zetocha K; Smolenski DJ; Holloway KM; Rothbaum BO; Difede J; Rizzo AA; Edwards-Stewart A; Skopp NA; Mishkind M; Reger MA; Gahm GA
    J Consult Clin Psychol; 2016 Nov; 84(11):946-959. PubMed ID: 27606699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
    Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
    Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancing exposure therapy for posttraumatic stress disorder (PTSD): a randomized clinical trial of virtual reality and imaginal exposure with a cognitive enhancer.
    Difede J; Rothbaum BO; Rizzo AA; Wyka K; Spielman L; Reist C; Roy MJ; Jovanovic T; Norrholm SD; Cukor J; Olden M; Glatt CE; Lee FS
    Transl Psychiatry; 2022 Jul; 12(1):299. PubMed ID: 35896533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Harm expectancy violation during exposure therapy for posttraumatic stress disorder.
    de Kleine RA; Hendriks L; Becker ES; Broekman TG; van Minnen A
    J Anxiety Disord; 2017 Jun; 49():48-52. PubMed ID: 28399468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome.
    Yehuda R; Bierer LM; Pratchett LC; Lehrner A; Koch EC; Van Manen JA; Flory JD; Makotkine I; Hildebrandt T
    Psychoneuroendocrinology; 2015 Jan; 51():589-97. PubMed ID: 25212409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virtual reality exposure versus prolonged exposure for PTSD: Which treatment for whom?
    Norr AM; Smolenski DJ; Katz AC; Rizzo AA; Rothbaum BO; Difede J; Koenen-Woods P; Reger MA; Reger GM
    Depress Anxiety; 2018 Jun; 35(6):523-529. PubMed ID: 29734488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.